2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
12
Leukemia
12
Breast Neoplasms
11
Leukemia, Myeloid, Acute
9
Congenital Abnormalities
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
7
Multiple Myeloma
7
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Waldenstrom Macroglobulinemia
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Chronic-Phase
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Burkitt Lymphoma
5
Squamous Cell Carcinoma of Head and Neck
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma
4
Lung Neoplasms
4
Leukemia, Myeloid, Accelerated Phase
4
Head and Neck Neoplasms
4
Central Nervous System Neoplasms
4
Blast Crisis
4
Sezary Syndrome
3
Interventions
Cisplatin
161
Fluorouracil
135
Paclitaxel
127
Radiotherapy
125
Oxaliplatin
88
Carboplatin
72
Docetaxel
71
Irinotecan
60
pembrolizumab
57
Leucovorin
57
Capecitabine
57
Radiation
48
Esophagectomy
44
Surgical Procedures, Operative
41
Drug Therapy
38
Neoadjuvant Therapy
28
Cetuximab
25
Nivolumab
24
Bevacizumab
21
camrelizumab
20
Trastuzumab
20
S 1 (combination)
19
Chemoradiotherapy
19
Magnetic Resonance Spectroscopy
18
Epirubicin
16
Albumin-Bound Paclitaxel
16
Blood Specimen Collection
15
tislelizumab
14
Taxes
14
Radiotherapy, Intensity-Modulated
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled